骨髓管 的英文怎麼說

中文拼音 [gǔsuǐguǎn]
骨髓管 英文
medullar canal
  • 骨 : 骨名詞1 （骨頭） bone2 （物體內部的支架） framework; skeleton 3 （品質; 氣概） character; spirit ...
  • 髓 : 名詞1. [生理學] （骨髓; 像骨髓的東西） marrow 2. [植物] （莖的中心部分） pith
  • 管 : Ⅰ名詞1 （管子） pipe; tube 2 （吹奏的樂器） wind musical instrument 3 （形狀似管的電器件） valve;...
  • 骨髓 : marrow; keest; medulla ossium; bone marrow骨髓白細胞 myeloplast; 骨髓病 myelopathy; myelopthy; os...
  1. Peripheral neuropathy also occurs with demyelization and degeneration of the axis cylinder.

    隨著骨髓的樞椎管的再生作用也產生末梢神經病。
  2. Adequate preoperative fluid hydration, intensive hemodynamic monitoring, ready - prepared blood and vasopressor drugs, inspiration of 100 percent oxygen, and copious irrigation of marrow debris after reaming are useful prophylactic methods to lower the catastrophic complication during cementation

    足夠的術前水分補給，手術中精細的生命徵象監視，隨時準備好的血液及增壓藥物以備不時之需，呼吸純氧以預防低血氧癥，在骨髓腔管被擴鉆后使用大量的水清洗骨髓腔管內的雜質，這些是降低骨水泥心臟血管衰竭並發癥發生的有效方法。
  3. Now it has been found the recruitment and homing of circulating endothelial cells ( cecs ) or their progenitors ( ceps ) released from the bone marrow is very important in tumor angiogenesis. we detected the cecs and ceps in 64 pb ( peripheral blood ) of tumor patients. we found the amount of cecs and ceps is higher in tumor patients than normal controls

    本項目應用流式細胞法對64例腫瘤患者及15例正常人，外周血中的循環血管內皮細胞（ circulatingendothelialcell ， cec ）以及骨髓來源的循環血管內皮前體細胞（ circulalingendothelialprecursor ， cep ）進行了檢測，證實了外周血中cec / cep的存在，發現腫瘤患者cec / cep含量高於正常對照組，提示腫瘤患者體內存在血管內皮及其前體細胞的動員。
  4. In this report, we mainly covered the following aspects of " tissue organ regeneration and replication in situ " : 1 ) procedures of tissue organd regeneration and replication and replication in clnical practice ; 2 ) the discover and existence of potentiald regenerative cell ( prc ) ; 3 ) the proliferation, differentiation and regeneration law of potential law of potential regenerative cells ; 4 ) study procedure on tissue organ regeneration and replication from prcs in vitro based on the model of full skin organ regeneration in situ after extensive in vitro, set up the method and technology of searching life regenerative substance required in tissue organ regeneration and replication in situ. in this study, first, the whole human body is divided into 206 function units, which are the " tissue organ " in regeneration study. then the histology foundation of tissue organ regeneration and replication in situ is set up. in ordre to prove the existence of the potential regenerative cells and their potential baility and function, we established clinical tracking rechnique of skin organ regeneration in situ ; meanwhile, several tissue organ regeneration and replication in vitro models which represent different kinds of runctions were sucessfully set up, with all these techniques and models, we confirmed : 1 ) the existence, function and ability of pptemtoa regenerative cells ; 2 ) the importance of life regenerative substance ; 3 ) the feasibility of tissue organ regeneration and replication in situ ; 4 ) the big value of tissue organ regeneration and replication in situ in life science and medicine progerss. we also showed the possible foreground of capture cancer with this method and technologh. in this report, nearly 200 photographs of several tissue organ regeneration and replication in situ or in vitro demonstrated the whole process of tissue organ and big organ entities regeneration and replication from cells. the results of tissue organ regeneration and replication in situ mainly include : 1 ) whole skin organ regeneration and replication in situ ; 2 ) gastrointestinal mucosa tissue organ regeneration in vitro ; 3 ) hair follicle tissue organ regeneration in situ or in vitro ; 4 ) never tissue organ regeneration in situ ; 5 ) pancreas tissue organ regeneration and replication in vitro ; 5 ) marrow tissue regeneration in vitro ; 6 ) renal glomerulus and tubule tissue organ tugeneraation in vitro ; 7 ) heart muscle regeneration in vitro, etcl. in order to let more and more people know and understand this technology of tissue organd regeneration and replication in situ, herein, for the first time, we publicize the key points of actualizing this technology. also, we publicized the technology procedures and the frame constitute of life substances. we bilieve this is a big contribution to human science

    本研究報告，重點報道了組織器官的原位再生復制的臨床程序，報道了組織潛能再生細胞的發現和存在，以及該細胞的增殖分化和形成組織器官的變化規律.以燒傷后皮膚組織器官的原位再生復制為模型，研究出了體外組織潛能再生細胞復制組織器官的培養方法;以體外組織器官的復制為模型，建立了尋找原位組織器官再生復制所需生命物質的方法和技術.本研究，首先按人體的器官功能，分解為206個功能單位，確立了所復制的人體器官中的組織功能單位為組織器官，從而建立了原位組織器官再生復制的組織學基礎.為了驗證組織潛能再生細胞的再生潛能，建立了皮膚器官原位再生的實體臨床跟蹤技術，同時又建立了能代表有關器官功能類別的代表組織器官的原位和體外復制模型，以多組織器官的成功復制確定潛能再生細胞的作用，確定生命研究再生物質的重要性，確定組織器官原位再生復制的可行性，確定了組織器官原位再生復制的生命科學研究和醫學進步的重大應用價值，同時展示了用此方法和技術攻克癌癥的前景.本研究報告，以近二百幅多個組織器官原位和體外再生復制的實體圖片，展示了潛能再生細胞復制的組織器官和大器官司實體;展示了細胞再生復制器官的全過程.真實的報告了組織器官原位再生復制的成果.所公布的主要成果為:皮膚器官的原位再生復制;胃腸黏膜組織器官的原位和體外再生復制;毛囊組織器官的原位和體外再生復制;神經組織器官的原位復制;胰腺組織器官的體外復制;骨髓組織的體外復制;腎小球小管組織器官的體外復制;心肌的體外復制等.為了讓更多的人學會和掌握組織器官原位再生復制技術，本報告首次公布實施技術的重要環節和技術流程;首次公布了生命再生物質的框架和組成.作者自費研究成果對人類生命科學的一大貢獻
  5. In ha s knowledge, only about 20 public hospital patients requiring glivec as second line treatment for cml had shouldered the full cost of the drug themselves during the same time period

    據醫管局所知，同一期間只有約二十名需要加以域作為慢性骨髓性白血病第二線治療藥物的公立醫院病人自行負擔全部藥費。
  6. It has been reported that " glivec " for the treatment of gastrointestinal stromal tumour and chronic myeloid leukaemia has been classified by the hospital authority ( ha ) as first - line drug, and patients who have to take the drug and have financial difficulties will be referred to apply for drug subsidy from the samaritan fund

    據報，醫院管理局（醫管局）將治療胃腸基質瘤及慢性骨髓性白血病的藥物加以域定為第一線藥物，並會安排須服用該藥物而有經濟困難的病人申請撒瑪利亞基金的藥費資助。
  7. Hospital infection management of clean bone marrow transplantation unit

    潔凈骨髓移植病區的醫院感染管理
  8. Effect of bone marrow cells in the recovery of acute tubular necrosis due to glycerine in mice

    骨髓細胞參與甘油引起的小鼠急性腎小管壞死修復的實驗觀察
  9. Treatment of non - union of femoral fracture in aged patients by transplantation of vascularized fibula into medullary cavity with ni - ti - shaped memory alloy of embracing internal fixator

    吻合血管腓骨髓腔內移植記憶合金環抱接骨器固定治療老年人股骨幹骨折不愈合
  10. As a proteasome inhibitor, bortezomib has shown inhibition on cell proliferation, inducing cell apoptosis, inhibition of cell adhension and inhibition of tumor angiogenesis for multiple myeloma cells

    摘要硼替佐米作為一種蛋白酶抑制劑，對多發性骨髓瘤細胞表現出抑制細胞生長、誘導腫瘤細胞凋亡、抑制細胞粘附、抑制腫瘤血管生成等作用，同時對血液系統其他惡性腫瘤具有顯著的作用。
  11. Subset change of decidual nk cells infected by toxoplasma gondii during early pregnancy

    骨髓內皮祖細胞促帶蒂皮瓣血管化的實驗研究
  12. At high magnification, metastatic infiltrating ductal carcinoma of breast is seen within bone and filling the marrow cavity

    高倍放大顯示轉移的乳腺浸潤性導管癌，骨內和骨髓腔內布滿這種轉移性病變。
  13. All the complications happened in either the patients receiving cemented intramedullary nail for pathological femoral fracture or cemented bipolar hemiarthroplasty for hip fracture

    所有的這些心臟血管衰竭並發癥發生在病理性股骨骨折接受骨水泥骨髓腔內鋼釘的病人，或股骨頸骨折接受骨水泥兩極式人工股骨頭置換術的病人。
  14. The timing of onset of cardiovascular collapse most occurred immediately after impacting the implant into a cemented canal, but it might delay ten minutes as in our cases

    在我們的報告中，發生心臟血管衰竭並發癥的時間大部分是在將骨內鋼釘或兩極式人工股骨頭打入灌有骨水泥的骨髓腔后馬上發生，但可延遲到十分鐘后才發生。
  15. Risk factors are old age, poor cardiopulmonary compliance, pathological fracture, osteoporosis, large amount of cement, excessive pressurization with cement gun, and a previously undis - trubed intramedullary canal

    危險因子包括老年人，術前較差的心肺狀態，病理性骨折，骨質疏鬆，使用大量的骨水泥或骨水泥槍以進行骨髓腔管內加壓作用，未曾被擴鉆過的骨髓腔。
  16. Adult human bone marrow stromal cells were induced into endothelial cells by bfgf and egf

    誘導成人骨髓基質細胞向血管內皮細胞分化的實驗研究
  17. Transplantation of allogenetic bone marrow mesenchymal stem cells combined with vascular endothelial growth factor gene transfection for treating myocardial infarction

    同種異體骨髓間質幹細胞移植聯合血管內皮細胞生長因子基因轉染治療心肌梗死
  18. His research interests focus on differentiation and expansion of bone marrow derived neural stem cells and endothelial progenitor cells, and cell therapy in the context of cerebral ischemia repair

    主要研究方向為：骨髓源性神經幹細胞和血管內皮祖細胞誘導分化、體外擴增，以及腦缺血的細胞治療。
  19. Angiogenic effect of bone marrow mesenchymal stem cells transfected with human vegf gene on myocardial infarcts in rats

    基因轉染骨髓間充質幹細胞對大鼠心梗區血管新生的影響
  20. The recent years saw successful investigation into the novel use of autologous bone marrow transplant for enhancement of neovascularisation in patients with " end - stage " ischaemic heart disease, which is a potentially safer, cheaper and more effective method for therapeutic angiogenesis than using angiogenic growth factors

    近年來，醫學院就自體骨髓移植這項嶄新技術取得了重大的進展，更能提升末期?血心臟病患者的血管新生。相對于傳統利用血管生長因子，這項用於治療性血管新生的技術，可說是更有效、更安全且更便宜。
分享友人
分享到 Line

分享到臉書